Deep brain stimulation of hippocampus in treatment of refractory temporal lobe epilepsy
Abstract
Introduction. Temporal lobe epilepsy (TLE) is the most common cause of focal onset seizures, affecting 40% of adolescents and adults with epilepsy. TLE is also one of the most common drug resistant forms of epilepsy. Surgical resection remains the treatment of choice for TLE, but not all patients with TLE are suitable candidates for resective neurosurgery. For such patients, deep brain stimulation (DBS) of the hippocampus remains a reversible and efficient treatment alternative. State of the art. We undertook a systematic review of the literature on hippocampal DBS efficacy and safety in the management of patients with TLE. A search using two electronic databases, the Medical Literature, Analysis, and Retrieval System on-line (MEDLINE) and the Cochrane Central Register of Controlled Trials (CEN-TRAL), was conducted. Clinical implications. We found 14 articles related to hippocampal DBS for the treatment of TLE. The responder rate (defined as at least 50% reduction in seizure frequency) for all patients was 83.4%, Of 99 patients treated by hippocampal DBS, 82 were regarded as responders, and 17 as non-responders. Future directions. Hippocampal DBS appears to be a safe and efficacious treatment alternative for patients who are not candidates for temporal lobectomy or selective amygdalohippocampectomy due to serious postoperative cognitive deficits. In selected patients with TLE, this neuromodulatory therapy may be very safe and efficacious.
Keywords: deep brain stimulationhippocampal stimulationtemporal lobe epilepsyhippocampal sclerosisneuromodulation
References
- Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology. 2007; 68(5): 326–337.
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5): 314–319.
- Asadi-Pooya AA, Stewart GR, Abrams DJ, et al. Prevalence and Incidence of Drug-Resistant Mesial Temporal Lobe Epilepsy in the United States. World Neurosurg. 2017; 99: 662–666.
- Dutra JR, Cortés EP, Vonsattel JP. Update on Hippocampal Sclerosis. Curr Neurol Neurosci Rep. 2015; 15(10): 67.
- Engel J, McDermott MP, Wiebe S, et al. Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012; 307(9): 922–930.
- Sperling M, Feldman H, Kinman J, et al. Seizure control and mortality in epilepsy. Annals of Neurology. 2001; 46(1): 45–50, doi: 10.1002/1531-8249(199907)46:1<45::aid-ana8>3.0.co;2-i.
- Berg AT, Vickrey BG, Langfitt JT, et al. Multicenter Study of Epilepsy Surgery. The multicenter study of epilepsy surgery: recruitment and selection for surgery. Epilepsia. 2003; 44(11): 1425–1433.
- Harroud A, Bouthillier A, Weil AG, et al. Temporal lobe epilepsy surgery failures: a review. Epilepsy Res Treat. 2012; 2012: 201651.
- Jung R, Aull-Watschinger S, Moser D, et al. Is reoperation an option for patients with temporal lobe epilepsy after failure of surgery? Seizure. 2013; 22(7): 502–506.
- Kapur N, Prevett M. Unexpected amnesia: are there lessons to be learned from cases of amnesia following unilateral temporal lobe surgery? Brain. 2003; 126(Pt 12): 2573–2585.
- Ding P, Zhang S, Zhang J, et al. Contralateral Hippocampal Stimulation for Failed Unilateral Anterior Temporal Lobectomy in Patients with Bilateral Temporal Lobe Epilepsy. Stereotact Funct Neurosurg. 2016; 94(5): 327–335.
- Ma BB, Rao VR. Responsive neurostimulation: Candidates and considerations. Epilepsy Behav. 2018; 88: 388–395.
- Wheless JW, Gienapp AJ, Ryvlin P. Vagus nerve stimulation (VNS) therapy update. Epilepsy Behav. 2018; 88S: 2–10.
- Geller EB, Skarpaas TL, Gross RE, et al. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia. 2017; 58(6): 994–1004.
- Rohatgi P, Jafrani RJ, Brandmeir NJ, et al. Robotic-Guided Bihippocampal and Biparahippocampal Depth Placement for Responsive Neurostimulation in Bitemporal Lobe Epilepsy. World Neurosurg. 2018; 111: 181–189.
- McInnes MDF, Moher D, Thombs BD, et al. and the PRISMA-DTA Group. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018; 319(4): 388–396.
- Benbadis SR, Geller E, Ryvlin P, et al. Putting it all together: Options for intractable epilepsy: An updated algorithm on the use of epilepsy surgery and neurostimulation. Epilepsy Behav. 2018; 88S: 33–38.
- Geller EB. Responsive neurostimulation: Review of clinical trials and insights into focal epilepsy. Epilepsy Behav. 2018; 88S: 11–20.
- King-Stephens D, Mirro E, Weber PB, et al. Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography. Epilepsia. 2015; 56(6): 959–967.
- DiLorenzo DJ, Mangubat EZ, Rossi MA, et al. Chronic unlimited recording electrocorticography-guided resective epilepsy surgery: technology-enabled enhanced fidelity in seizure focus localization with improved surgical efficacy. J Neurosurg. 2014; 120(6): 1402–1414.
- Velasco M, Velasco F, Velasco AL, et al. Subacute electrical stimulation of the hippocampus blocks intractable temporal lobe seizures and paroxysmal EEG activities. Epilepsia. 2000; 41(2): 158–169.
- Cuéllar-Herrera M, Velasco M, Velasco F, et al. Evaluation of GABA system and cell damage in parahippocampus of patients with temporal lobe epilepsy showing antiepileptic effects after subacute electrical stimulation. Epilepsia. 2004; 45(5): 459–466.
- Vonck K, Boon P, Achten E, et al. Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy. Ann Neurol. 2002; 52(5): 556–565.
- McLachlan RS, Pigott S, Tellez-Zenteno JF, et al. Hippocampal electrical stimulation in mesial temporal lobe epilepsy. Neurology. 2006; 66(10): 1490–1494.
- Velasco AL, Velasco F, Velasco M, et al. Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study. Epilepsia. 2007; 48(10): 1895–1903.
- Boëx C, Vulliémoz S, Spinelli L, et al. High and low frequency electrical stimulation in non-lesional temporal lobe epilepsy. Seizure. 2007; 16(8): 664–669.
- Boon P, Vonck K, De Herdt V, et al. Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia. 2007; 48(8): 1551–1560.
- McLachlan RS, Pigott S, Tellez-Zenteno JF, et al. Bilateral hippocampal stimulation for intractable temporal lobe epilepsy: impact on seizures and memory. Epilepsia. 2010; 51(2): 304–307.
- Boëx C, Seeck M, Vulliémoz S, et al. Chronic deep brain stimulation in mesial temporal lobe epilepsy. Seizure. 2011; 20(6): 485–490.
- Cukiert A, Cukiert CM, Burattini JA, et al. Seizure outcome after hippocampal deep brain stimulation in a prospective cohort of patients with refractory temporal lobe epilepsy. Seizure. 2014; 23(1): 6–9.
- Bondallaz P, Boëx C, Rossetti AO, et al. Electrode location and clinical outcome in hippocampal electrical stimulation for mesial temporal lobe epilepsy. Seizure. 2013; 22(5): 390–395.
- Vonck K, Sprengers M, Carrette E, et al. A decade of experience with deep brain stimulation for patients with refractory medial temporal lobe epilepsy. Int J Neural Syst. 2013; 23(1): 1250034.
- Cukiert A, Cukiert CM, Burattini JA, et al. Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy: A prospective, controlled, randomized, double-blind study. Epilepsia. 2017; 58(10): 1728–1733.
- Cukiert A, Cukiert CM, Burattini JA, et al. Long-term seizure outcome during continuous bipolar hippocampal deep brain stimulation in patients with temporal lobe epilepsy with or without mesial temporal sclerosis: An observational, open-label study. Epilepsia. 2021; 62(1): 190–197.
- McLachlan RS, Pigott S, Tellez-Zenteno JF, et al. Bilateral hippocampal stimulation for intractable temporal lobe epilepsy: impact on seizures and memory. Epilepsia. 2010; 51(2): 304–307.
- Min B, Guoming L, Jian Z. Treatment of mesial temporal lobe epilepsy with amygdalohippocampal stimulation: A case series and review of the literature. Exp Ther Med. 2013; 5(4): 1264–1268.
- Jin H, Li W, Dong C, et al. Hippocampal deep brain stimulation in nonlesional refractory mesial temporal lobe epilepsy. Seizure. 2016; 37: 1–7.
- Lim SA, Lee CY, Lee ST, et al. Low and high freqiuency hippocampal stimulation for drug-resistent mesial temporal lobe epilepsy. Neuromodulation. 2016; 19: 365–372.
- Vázquez-Barrón D, Cuéllar-Herrera M, Velasco F, et al. Electrical Stimulation of Subiculum for the Treatment of Refractory Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A 2-Year Follow-Up Study. Stereotact Funct Neurosurg. 2021; 99(1): 40–47.
- Saucedo-Alvarado PE, Velasco AL, Aguado-Carrillo G, et al. Optimizing deep brain stimulation for the treatment of drug-resistant temporal lobe epilepsy: a pilot study. J Neurosurg. 2022; 137(3): 768–775.
- Wang S, Zhao M, Li T, et al. Long-term efficacy and cognitive effects of bilateral hippocampal deep brain stimulation in patients with drug-resistant temporal lobe epilepsy. Neurol Sci. 2021; 42(1): 225–233.
- Hirsch LJ, Mirro EA, Salanova V, et al. Mesial temporal resection following long-term ambulatory intracranial EEG monitoring with a direct brain-responsive neurostimulation system. Epilepsia. 2020; 61(3): 408–420.
- King-Stephens D, Mirro E, Weber PB, et al. Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography. Epilepsia. 2015; 56(6): 959–967.
- Nunna RS, Borghei A, Brahimaj BC, et al. Responsive Neurostimulation of the Mesial Temporal White Matter in Bilateral Temporal Lobe Epilepsy. Neurosurgery. 2021; 88(2): 261–267.
- Jobst BC, Kapur R, Barkley GL, et al. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia. 2017; 58(6): 1005–1014.
- Swanson TH. The pathophysiology of human mesial temporal lobe epilepsy. J Clin Neurophysiol. 1995; 12(1): 2–22.
- Lehmann TN, Gabriel S, Kovacs R, et al. Alterations of neuronal connectivity in area CA1 of hippocampal slices from temporal lobe epilepsy patients and from pilocarpine-treated epileptic rats. Epilepsia. 2000; 41 Suppl 6: S190–S194.
- Raedt R, Van Dycke A, Vonck K, et al. Cell therapy in models for temporal lobe epilepsy. Seizure. 2007; 16(7): 565–578.
- Sperling MR, O'Connor MJ, Saykin AJ, et al. A noninvasive protocol for anterior temporal lobectomy. Neurology. 1992; 42(2): 416–422.
- Cohen I, Navarro V, Clemenceau S, et al. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science. 2002; 298(5597): 1418–1421.
- Knopp A, Frahm C, Fidzinski P, et al. Loss of GABAergic neurons in the subiculum and its functional implications in temporal lobe epilepsy. Brain. 2008; 131(Pt 6): 1516–1527.
- Karunakaran S, Rollo MJ, Kim K, et al. The interictal mesial temporal lobe epilepsy network. Epilepsia. 2018; 59(1): 244–258.
- Haugland KG, Sugar J, Witter MP. Development and topographical organization of projections from the hippocampus and parahippocampus to the retrosplenial cortex. Eur J Neurosci. 2019; 50(1): 1799–1819.
- Stroup E, Langfitt J, Berg M, et al. Predicting verbal memory decline following anterior temporal lobectomy (ATL). Neurology. 2003; 60(8): 1266–1273.
- Dulay MF, York MK, Soety EM, et al. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006; 47(11): 1922–1930.
- Fisher R, Salanova V, Witt T, et al. SANTE Study Group. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010; 51(5): 899–908.
- Rusinek J, Porębska K, Sawczyńska K, et al. Visual disturbances in patients with Parkinson's Disease treated with oral medications or deep brain stimulation. Neurol Neurochir Pol. 2023; 57(4): 392–396.
- Bistriceanu CE, Stoleriu I, Cuciureanu DI. Default mode function in patients with generalised epilepsy syndromes: from generalised to focal findings. Neurol Neurochir Pol. 2023; 57(6): 477–483.
- Mazurkiewicz-Bełdzińska M, Zawadzka M. Use of cannabidiol in the treatment of epilepsy. Neurol Neurochir Pol. 2022; 56(1): 14–20.
- Bosak M, Dziedzic R, Matwiej K, et al. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series. Neurol Neurochir Pol. 2024; 58(2): 203–206.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)